Hib cases rise during vaccine shortage

Minnesota health officials are drawing a link between the shortage of Merck's Hib childhood vaccine and an increase in that disease, which can cause meningitis and pneumonia. They are reporting five cases of Hib, including one death, for 2008; that's the highest level since the early 1990s, when Hib vaccination grew widespread. Report

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.